Rafferty Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.2M Buy
39,896
+4,480
+13% +$1.82M 0.05% 185
2025
Q1
$17.6M Sell
35,416
-7,965
-18% -$3.96M 0.08% 159
2024
Q4
$22.6M Buy
43,381
+4,636
+12% +$2.41M 0.08% 139
2024
Q3
$24M Sell
38,745
-2,769
-7% -$1.71M 0.08% 131
2024
Q2
$23M Buy
41,514
+1,639
+4% +$906K 0.09% 124
2024
Q1
$23.2M Buy
39,875
+540
+1% +$314K 0.09% 126
2023
Q4
$20.9M Sell
39,335
-934
-2% -$496K 0.09% 135
2023
Q3
$20.4M Buy
40,269
+2,944
+8% +$1.49M 0.12% 114
2023
Q2
$19.5M Buy
37,325
+2,230
+6% +$1.16M 0.11% 116
2023
Q1
$20.2M Buy
35,095
+1,265
+4% +$729K 0.14% 108
2022
Q4
$18.6M Buy
33,830
+12,788
+61% +$7.04M 0.16% 105
2022
Q3
$10.7M Buy
21,042
+11,468
+120% +$5.82M 0.11% 137
2022
Q2
$5.2M Sell
9,574
-2,555
-21% -$1.39M 0.05% 271
2022
Q1
$7.16M Sell
12,129
-1,211
-9% -$715K 0.04% 263
2021
Q4
$8.9M Buy
13,340
+797
+6% +$532K 0.05% 210
2021
Q3
$7.17M Buy
12,543
+4,337
+53% +$2.48M 0.05% 228
2021
Q2
$4.14M Buy
8,206
+666
+9% +$336K 0.03% 382
2021
Q1
$3.44M Buy
7,540
+899
+14% +$410K 0.02% 398
2020
Q4
$3.09M Sell
6,641
-524
-7% -$244K 0.03% 342
2020
Q3
$3.16M Sell
7,165
-1,743
-20% -$769K 0.04% 271
2020
Q2
$3.23M Buy
8,908
+5,823
+189% +$2.11M 0.05% 253
2020
Q1
$875K Sell
3,085
-7,742
-72% -$2.2M 0.04% 254
2019
Q4
$3.52M Buy
10,827
+10,103
+1,395% +$3.28M 0.05% 195
2019
Q3
$211K Hold
724
﹤0.01% 774
2019
Q2
$213K Sell
724
-23
-3% -$6.77K ﹤0.01% 774
2019
Q1
$204K Buy
+747
New +$204K ﹤0.01% 762
2018
Q2
Sell
-2,368
Closed -$489K 702
2018
Q1
$489K Buy
+2,368
New +$489K 0.01% 586
2016
Q3
Sell
-3,889
Closed -$575K 532
2016
Q2
$575K Buy
+3,889
New +$575K 0.04% 353
2016
Q1
Sell
-5,862
Closed -$832K 571
2015
Q4
$832K Sell
5,862
-1,669
-22% -$237K 0.1% 268
2015
Q3
$921K Sell
7,531
-1,624
-18% -$199K 0.07% 219
2015
Q2
$1.19M Sell
9,155
-1,740
-16% -$226K 0.08% 183
2015
Q1
$1.46M Buy
+10,895
New +$1.46M 0.11% 162